高级检索

    CT、MRI及超声造影对肝脏局灶性病变良恶性鉴别的诊断效能分析

    Diagnostic performance of CT, MRI and contrast-enhanced ultrasound in differentiating benign and malignant focal liver lesions

    • 摘要: 目的 评估CT、MRI、超声造影(CEUS)单独及联合应用在肝脏局灶性病变(FLL)良恶性鉴别中的诊断价值。方法 选取2022年1月—2024年5月在徐州医科大学附属医院诊治的FLL患者130例,以病理结果为金标准,采用受试者工作特征(ROC)曲线分析CT、MRI、CEUS及其联合应用鉴别FLL良恶性的价值,并比较各方法鉴别FLL良恶性的敏感度、特异度、阳性预测值、阴性预测值和准确率。结果 病理确诊良性病变69例(53.1%),恶性病变61例(46.9%)。ROC曲线显示CT、MRI、CEUS及联合应用鉴别FLL良恶性的曲线下面积(AUC)分别为0.775、0.901、0.822、0.924。DeLong检验证实MRI与联合应用的诊断效能优于CT和CEUS(P<0.05),其中联合应用诊断效能最高,但与MRI的差异无统计学意义。不同影像学方法鉴别FLL良恶性的敏感度、阴性预测值及准确率的差异有统计学意义(P<0.05)。联合应用在上述三项指标中均表现最佳,其敏感度、阴性预测值及准确率分别为93.44%、94.03%和92.31%。联合应用及MRI的敏感度均显著高于CT和CEUS(P<0.05)。联合应用及MRI阴性预测值均高于CT,且联合应用亦高于CEUS(P<0.05)。MRI及联合应用准确率均高于CT,其中联合应用的诊断准确率最高(P<0.05)。各影像学方法特异度及阳性预测值方面的差异均无统计学意义(P>0.05)。结论 CT、MRI和CEUS联合应用可显著提高FLL良恶性鉴别的诊断效能,其中MRI单项诊断价值突出,联合应用在阴性预测值和总体准确率方面有优势。

       

      Abstract: Objective To evaluate the diagnostic value of CT, MRI and contrast-enhanced ultrasound (CEUS), alone and in combination, in differentiating benign and malignant focal liver lesions (FLL). Methods A total of 130 patients with FLL who were diagnosed and treated at the Affiliated Hospital of Xuzhou Medical University between January 2022 and May 2024 were enrolled. Pathological results were used as the gold standard. Receiver operating characteristic (ROC) curves were plotted to assess the value of CT, MRI, CEUS, and their combined application in differentiating benign and malignant FLL. Sensitivity, specificity, positive predictive value, negative predictive value, and diagnostic accuracy of each imaging modality were compared. Results Pathological examination confirmed 69 cases (53.1%) of benign lesions and 61 cases (46.9%) of malignant lesions. ROC curve analysis showed that the areas under the curve (AUCs) for CT, MRI, CEUS, and the combined application in differentiating benign and malignant FLL were 0.775, 0.901, 0.822, and 0.924, respectively. DeLong tests demonstrated that the diagnostic performance of MRI and the combined application was superior to that of CT and CEUS (P<0.05). The combined application showed the highest diagnostic efficiency, although the difference compared with MRI alone was not statistically significant. Significant differences were observed among the imaging modalities in terms of sensitivity, negative predictive value, and accuracy (P<0.05). The combined application achieved the optimal performance for these three indicators, with a sensitivity of 93.44%, a negative predictive value of 94.03%, and an overall diagnostic accuracy of 92.31%. The sensitivities of MRI and the combined application were both significantly higher than those of CT and CEUS (P<0.05). Regarding negative predictive value, MRI and the combined application were superior to CT, and the combined application was also superior to CEUS (P<0.05). In terms of diagnostic accuracy, MRI and the combined application outperformed CT, with the combined application showing the highest accuracy. No statistically significant differences were observed among the imaging modalities with respect to specificity or positive predictive value (P>0.05). Conclusions The combined application of CT, MRI, and CEUS can significantly improve the diagnostic performance in differentiating benign and malignant FLL. MRI alone demonstrates high diagnostic value, while the combined approach offers advantages in negative predictive value and overall diagnostic accuracy.

       

    /

    返回文章
    返回